PURPOSE: The negative association between obstructive sleep apnea (OSA) and adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI) is well documented. Continue reading →

In this study, we screened potential natural compounds for the treatment ofmyocardial infarction(MI) and explored the underlying mechanisms. Continue reading →

AIM AND OBJECTIVES: To examine the dissimilarity between Chinesemyocardial infarction(MI) patients and spouses illness perceptions, and to explore the relationship between patients IP, differences in couples IP and patients lifestyle after discharge. An individuals illness perception is affected and moderated by several factors, including the social context. One of the most influential members of the social network of patients is the spouse Continue reading →

BACKGROUND: Cardiovascular disease including ST elevationmyocardial infarction(STEMI) is increasing and the leading cause of death in China. Continue reading →

BACKGROUND: Information about causes of death in patients withmyocardialinjury is limited. The purpose of this study was to explore causes of death in patients withmyocardialinjury. In a cohort of 22,589 patients, 3,853 patients withmyocardialinjury were identified and categorized into: type 1myocardial infarction, type 2myocardial infarction, and non-ischemic acute and chronicmyocardialinjury. Continue reading →

Among patients aged 80 or older, high adherence to statins after a myocardial infarction appears to be associated with improved survival. Continue reading →

Complete revascularization has demonstrated consistent long-term benefit over culprit-lesion-only percutaneous coronary intervention (PCI) among patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, regardless of nonculprit-lesion intervention timing. This research was recently published in the Journal of the American College of Cardiology. This study included 4041 individuals with multivessel coronary artery disease and STEMI, 49.9% (n=2016) of whom were randomly assigned to nonculprit-lesion PCI and 50.1% (n=2025) of whom were randomly assigned to culprit-lesion-only PCI Continue reading →

BACKGROUND: The prognostic value ofmyocardialperfusion imaging (MPI) in patients with known coronary artery disease (CAD) and high exercise capacity is still unknown. We sought to determine the MPI additional prognostic value over electrocardiography (ECG) stress testing alone in patients with known CAD who achieved10 metabolic equivalents (METs) Continue reading →